BOM:532872 (India)
Â
Ordinary Shares
₹
208.1
+2.05 (+0.99%)
Aug 3
Business Description
Sun Pharma Advanced Research Co Ltd
ISIN : INE232I01014
Share Class Description:
BOM:532872: Ordinary SharesTotal Employee Number:
316Compare
Compare
Traded in other countries / regions
532872.India IPO Date
2007-07-18Description
Sun Pharma Advanced Research Co Ltd is engaged in the research and development of pharmaceutical products and is a clinical-stage biopharmaceutical company focused on developing therapeutics to improve standards of care for patients. Its research and development activities include oncology, immunology, research programs, and the R&D pipeline. The Company generates maximum revenue within India and also operates outside India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 0.35 | |||||
Interest Coverage | 46.54 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.46 | |||||
Beneish M-Score | 1.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.6 | |||||
3-Year FCF Growth Rate | -39.7 | |||||
3-Year Book Growth Rate | 37.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.58 | |||||
9-Day RSI | 31.19 | |||||
14-Day RSI | 37.42 | |||||
3-1 Month Momentum % | 67.41 | |||||
6-1 Month Momentum % | 71.43 | |||||
12-1 Month Momentum % | 60.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.47 | |||||
Days Sales Outstanding | 1.96 | |||||
Days Payable | 810.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.16 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 97.54 | |||||
Operating Margin % | 84.54 | |||||
Net Margin % | 82.65 | |||||
EBITDA Margin % | 85 | |||||
FCF Margin % | -13.97 | |||||
OCF Margin % | -12.71 | |||||
ROE % | 599.51 | |||||
ROA % | 164.72 | |||||
ROIC % | 143.89 | |||||
3-Year ROIIC % | 109.48 | |||||
ROC (Joel Greenblatt) % | 245.51 | |||||
ROCE % | 393.94 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 4.4 | |||||
Forward PE Ratio | 3.45 | |||||
PE Ratio without NRI | 4.38 | |||||
PS Ratio | 3.64 | |||||
PB Ratio | 5.11 | |||||
Price-to-Tangible-Book | 5.33 | |||||
EV-to-EBIT | 4.61 | |||||
EV-to-EBITDA | 4.57 | |||||
EV-to-Revenue | 3.89 | |||||
EV-to-FCF | -28.86 | |||||
Price-to-GF-Value | 2.51 | |||||
Price-to-Median-PS-Value | 0.08 | |||||
Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 6.55 | |||||
Earnings Yield (Greenblatt) % | 21.69 | |||||
FCF Yield % | -3.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sun Pharma Advanced Research Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 18,791.7 | ||
| EPS (TTM) (₹) | 47.85 | ||
| Beta | 1.4301 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.38 | ||
| Volatility % | 59.9 | ||
| 14-Day RSI | 37.42 | ||
| 14-Day ATR (₹) | 10.67715 | ||
| 20-Day SMA (₹) | 233.945 | ||
| 12-1 Month Momentum % | 60.02 | ||
| 52-Week Range (₹) | 108.2 - 289 | ||
| Shares Outstanding (Mil) | 324.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sun Pharma Advanced Research Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sun Pharma Advanced Research Co Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sun Pharma Advanced Research Co Ltd Frequently Asked Questions
What is Sun Pharma Advanced Research Co Ltd(BOM:532872)'s stock price today?
The current price of BOM:532872 is ₹208.10. The 52 week high of BOM:532872 is ₹289.00 and 52 week low is ₹108.20.
When is next earnings date of Sun Pharma Advanced Research Co Ltd(BOM:532872)?
The next earnings date of Sun Pharma Advanced Research Co Ltd(BOM:532872) is .
Does Sun Pharma Advanced Research Co Ltd(BOM:532872) pay dividends? If so, how much?
Sun Pharma Advanced Research Co Ltd(BOM:532872) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway | 2021-06-08 |
Articles on Sun Pharma Advanced Research Co Ltd
No articles.